510(k) K212248

GlucoLeader Enhance 2 Blood Glucose Monitoring System by Hmd Biomedical, Inc. — Product Code NBW

K212248 is an FDA 510(k) premarket notification submitted by Hmd Biomedical, Inc. for the device "GlucoLeader Enhance 2 Blood Glucose Monitoring System". The FDA issued a decision of Substantially Equivalent on August 29, 2022. The device falls under product code NBW (System, Test, Blood Glucose, Over The Counter), a Class II device regulated under 21 CFR 862.1345. Hmd Biomedical, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
August 29, 2022
Date Received
July 19, 2021
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
System, Test, Blood Glucose, Over The Counter
Device Class
Class II
Regulation Number
862.1345
Review Panel
CH
Submission Type